Loading...

World-Class Retina Care. Community-Based Caring.

Recent Study Examined the Cytopathology and Prognostic Accuracy of the 15-GEP/PRAME Assay for Uveal Melanoma Metastasis

Posted On October 29, 2026 / By / Posted in Blog

Recent Study Examined the Cytopathology and Prognostic Accuracy of the 15-GEP/PRAME Assay for Uveal Melanoma Metastasis

As part of the Collaborative Ocular Oncology Group (COOG), Texas Retina’s Timothy Fuller, MD, recently participated in a multi-center clinical research cohort study to determine if the results of an additional cell examination

read more
Posted On October 23, 2026 / By / Posted in Blog

Texas Retina Opens Eight New Clinical Trials

At Texas Retina, we are committed to conducting ongoing research that could improve care for our patients — a value instilled by the pioneering physicians who founded our practice more than 50

read more
Posted On October 7, 2026 / By / Posted in Blog

Dr. Abbey Presents ARCHER II Clinical Trial Data at The Retina Society Annual Scientific Meeting

Texas Retina’s Ashkan Abbey, MD, presented baseline characteristics of participants in the Phase 3 ARCHER II clinical trial for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) at the 59th

read more
Posted On October 6, 2026 / By / Posted in Blog

A New Way to Explore Career Opportunities at Texas Retina

Texas Retina has launched a new Careers page to make it easier to learn about career opportunities and current openings within our organization. For more than six decades, Texas Retina has brought

read more
Posted On October 5, 2026 / By / Posted in Blog

Frequently Asked Questions About Eye Injections

For many retinal diseases like age-related macular degeneration, diabetic retinopathy, retinal vein occlusion and uveitis, an eye injection (also called an intravitreal injection) is the only way we can deliver potentially sight-saving medication where it is needed

read more